Hawley S, Cordtz R, Dreyer L, et al. Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis. Semin Arthritis Rheum. 2018;47(5):605-10....
NICE gives final guidance on apixaban for VTEThe article focuses on the new guidelines issued by the National Institute for Health and Clinical Excellence (NICE) of Great Britain for the prevention of venous thromboembolism (VTE) for adults undergoing total hip or knee replacement surgery....
Pharmacoepidemiology, Rheumatoid Arthritis, Biologic Therapy, Arthroplasty of Hip, Arthroplasty of KneeObjectiveTo estimate the impact of NICE approval of tumour necrosis factor inhibitor (TNFi) therapies on the incidence of total hip replacement (THR) and total knee replacement (TKR) among rheumatoid ...
The article focuses on the new guidelines issued by the National Institute for Health and Clinical Excellence (NICE) of Great Britain for the prevention of venous thromboembolism (VTE) for adults undergoing total hip or knee replacement surgery.EBSCO_AspPharmacoeconomics & Outcomes News...
Objective: To estimate the impact of NICE approval of tumor necrosis factor inhibitor (TNFi) therapies on the incidence of total hip replacement (THR) and total knee replacement (TKR) among rheumatoid arthritis (RA) patients in England and Wales.Hawley, SamuelCordtz, ReneDreyer, LeneEdwards, ...
EdwardsChristopherJ.ArdeningentaconnectSeminars in Arthritis & RheumatismHawley S, Cordtz R, Dreyer L, et al. Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis. ...
Venous thrombosis prophylaxis associated with hip and knee replacement over a ten year period a population based study. J Bone Joint Surg Br 2005; 87-B: 1675–80. Google Scholar3. Bjornara, B.T., Gudmundsen, T.E., Dahl, O.E.. Frequency and timing of clinical venous thromboembolism ...
Holmes M, Carroll C, Papaioannou D: Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip or knee surgery: a NICE single technology appraisal. Pharmacoeconomics. 2012 Feb 1;30(2):137-46. doi: 10.2165/11591590- 000000000-00000.[pubmed]...
Holmes M, Carroll C, Papaioannou D: Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip or knee surgery: a NICE single technology appraisal. Pharmacoeconomics. 2012 Feb 1;30(2):137-46. doi: 10.2165/11591590- 000000000-00000.[pubmed]...